Ann Intern Med:甲泼尼龙局部注射可有效治疗腕管综合征

2013-09-24 高晓方 译 医学论坛网

瑞典一项研究表明,甲泼尼龙局部注射可显著改善腕管综合征(CTS)短期症状并降低远期手术率。论文发表于《内科学年鉴》。 此项随机、安慰剂对照试验共纳入111例既往未接受过激素注射的CTS患者,并随机给予甲泼尼龙80 mg、40mg或安慰剂行局部注射。主要终点为10周时CTS症状严重度评分变化和1年时手术率。 结果显示,10周时甲泼尼龙80和40 mg组患者的CTS症状

瑞典一项研究表明,甲泼尼龙局部注射可显著改善腕管综合征(CTS)短期症状并降低远期手术率。论文发表于《内科学年鉴》。

此项随机、安慰剂对照试验共纳入111例既往未接受过激素注射的CTS患者,并随机给予甲泼尼龙80 mg、40mg或安慰剂行局部注射。主要终点为10周时CTS症状严重度评分变化和1年时手术率。

结果显示,10周时甲泼尼龙80和40 mg组患者的CTS症状严重度评分改善情况均优于安慰剂组(至基线差异-0.64和-0.88),但1年时无显著差异。甲泼尼龙80 mg、40 mg和安慰剂组的1年手术率分别为73%、81%和92%。与安慰剂组相比,甲泼尼龙80 mg组患者接受手术治疗的可能性较低(P=0.042)。在整合至手术时间的情况下,甲泼尼龙80 mg和40 mg组接受受试者治疗的可能性均较低。

原文阅读

Isam Atroshi, MD, PhD; Magnus Flondell, MD; Manfred Hofer, BSc; and Jonas Ranstam, PhD.Methylprednisolone Injections for the Carpal Tunnel Syndrome: A Randomized, Placebo-Controlled Trial.Ann Intern Med 2013 September 3.


    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
    2013-09-26 chg122
  4. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2033171, encodeId=4ea220331e1b4, content=<a href='/topic/show?id=0fc76981917' target=_blank style='color:#2F92EE;'>#甲泼尼龙#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69819, encryptionId=0fc76981917, topicName=甲泼尼龙)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=583c133, createdName=yuandd, createdTime=Thu Jan 30 12:18:00 CST 2014, time=2014-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276688, encodeId=e79f12e66889c, content=<a href='/topic/show?id=111485391f1' target=_blank style='color:#2F92EE;'>#腕管综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85391, encryptionId=111485391f1, topicName=腕管综合征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=08e4137, createdName=meichuangyi, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405647, encodeId=845b140564e05, content=<a href='/topic/show?id=a5404e589d7' target=_blank style='color:#2F92EE;'>#局部#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47589, encryptionId=a5404e589d7, topicName=局部)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d14c2562456, createdName=chg122, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1430412, encodeId=30161430412ef, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1606029, encodeId=9a88160602947, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1619365, encodeId=76fa161936543, content=<a href='/topic/show?id=8dd46061824' target=_blank style='color:#2F92EE;'>#有效治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60618, encryptionId=8dd46061824, topicName=有效治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Thu Sep 26 06:18:00 CST 2013, time=2013-09-26, status=1, ipAttribution=)]

相关资讯

NEJM:揭示被污染的甲泼尼龙注射所引发的真菌性脑膜炎

2012年10月25日--随着真菌性脑膜炎发病案例在美国持续地增长,医生们面临着如何提供早期的疗法来治疗患者,近日,刊登在国际杂志NEJM上的研究报告中,来自密歇根大学的研究者报道了真菌性脑膜炎爆发的情况以及相应的抗真菌性脑膜炎的相关疗法。 研究者表示,超过200名病例都是因为患者注射了受感染的类固醇导致的,很大一部分患者都为成年人,其中有许多患者都有共存性疾病,这就使得治疗难度加大。推荐的疗法